Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-11-044162)

Filing Details

Accession Number:: 0001209191-11-044162
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2011-08-15 13:28:51
Reporting Period:: 2011-08-12

Filing Date:: 2011-08-15
Accepted Time:: 2011-08-15 13:28:51
Original Submission Date:: 2011-08-15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
786947	Acura Pharmaceuticals Inc	ACUR	Pharmaceutical Preparations (2834)	110853640

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1056695	A Peter Clemens	C/O Acura Pharmaceuticals, Inc. 616 N. North Court, Suite 120 Palatine IL 60067	Senior Vp And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-15	2,000	$2.68	434,407	No	4	P	Direct
Common Stock	Acquisiton	2011-08-12	1,000	$2.65	3,605	No	4	P	Indirect	by son

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	by son

Footnotes

Amount of securities include 352,500 Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) in three equal installments on January 1st of each of 2012, 2013 and 2014.
This filing shall not be deemed an admission that the reporting person is the beneficial owner of these equity securities.